Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials

Objectives. To investigate changes in neutrophil count and occurrences of infection in RA patients treated with the IL-6 receptor-α inhibitor tocilizumab (TCZ). Methods. Data were pooled from patients who received i.v. TCZ (4 mg/kg + MTX, 8 mg/kg ± DMARDs, 10 mg/kg) or placebo + DMARDs in phase 3/4...

Descripción completa

Detalles Bibliográficos
Autores principales: Moots, Robert J., Sebba, Anthony, Rigby, William, Ostor, Andrew, Porter-Brown, Benjamin, Donaldson, Francis, Dimonaco, Sophie, Rubbert-Roth, Andrea, van Vollenhoven, Ronald, Genovese, Mark C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410975/
https://www.ncbi.nlm.nih.gov/pubmed/28013198
http://dx.doi.org/10.1093/rheumatology/kew370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410975/
https://www.ncbi.nlm.nih.gov/pubmed/28013198
http://dx.doi.org/10.1093/rheumatology/kew370

Ejemplares similares